Skip to main content
Shenzhen Bioeasy Biotechnology Co., Ltd. logo

Shenzhen Bioeasy Biotechnology Co., Ltd. — Investor Relations & Filings

Ticker · 300942 ISIN · CNE100004C78 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 910 across all filing types
Latest filing 2025-08-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300942

About Shenzhen Bioeasy Biotechnology Co., Ltd.

https://www.bioeasy.com

Shenzhen Bioeasy Biotechnology Co., Ltd. specializes in the development, production, and marketing of rapid testing solutions for food safety, clinical diagnosis, and animal health. The company provides a comprehensive portfolio of diagnostic products, including rapid test strips, enzyme-linked immunosorbent assay (ELISA) kits, and automated detection instruments. Its core focus areas include the detection of antibiotic residues, mycotoxins, pesticides, and foodborne pathogens in dairy, meat, seafood, and grain products. In the clinical sector, Bioeasy offers point-of-care testing (POCT) solutions for infectious diseases and chronic conditions. The company emphasizes research and development to deliver high-sensitivity, user-friendly diagnostic tools that meet international quality standards. Its products are utilized by food producers, regulatory agencies, and healthcare providers to ensure safety and quality control across the global supply chain.

Recent filings

Filing Released Lang Actions
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 13th meeting of the third board of directors of Shenzhen EasyBio Technology Co., Ltd. It includes details about the board meeting, voting results, and references to various reports such as the 2025 semi-annual report and a special report on the use of raised funds. The document does not contain the actual semi-annual report or financial statements but rather announces the board's approval of these reports and other corporate decisions. It also mentions that the full reports are available on an external website. The document is relatively short (2691 characters) and serves as a meeting resolution announcement rather than the report itself. Therefore, it fits best into the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2025-08-27 Chinese
董事会薪酬与考核委员会工作细则
Governance Information Classification · 95% confidence The document is titled '董事会薪酬与考核委员会工作细则' which translates to 'Board Remuneration and Assessment Committee Working Rules'. It details the structure, responsibilities, and procedures of the board's remuneration and assessment committee, including how remuneration policies are formulated, reviewed, and approved. It references governance-related laws and company bylaws, and focuses on internal governance mechanisms related to board and senior management compensation and assessment. There are no financial statements, earnings data, or regulatory filings of financial results. The content is about governance practices and internal rules regarding board remuneration and assessment. Therefore, the document fits best under Governance Information (CGR). The document length is 3390 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full annual report.
2025-08-27 Chinese
2025年半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 85% confidence The document is a summary table detailing non-operating fund occupation and other related party fund transactions for the half-year period of 2025. It contains financial data such as balances, amounts occupied, interest, and repayments related to affiliated companies and subsidiaries. The document is concise (1499 characters) and focuses on specific financial transactions and balances for a half-year period, but it does not present a comprehensive interim or quarterly financial report with full financial statements or substantive analysis. It is more of a financial summary related to related party transactions rather than a full interim report. Given the nature of the data and the half-year period reference, the closest fitting category is an Interim / Quarterly Report (IR), as it contains substantive financial data for a period shorter than a full fiscal year. Confidence is high because the document includes detailed financial figures for the half-year period, which aligns with the IR category requirements. H1 2025
2025-08-27 Chinese
2025年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2025年半年度募集资金存放与使用情况的专项报告" which translates to a "Special Report on the Deposit and Use of Raised Funds for the Half Year 2025." It details the amounts raised from IPO and convertible bonds, the use of these funds, their management, storage, and compliance with regulatory rules. It includes detailed tables on the use of funds, changes in project implementation, and cash management. The document is over 10,000 characters and contains substantive financial data and analysis related to the use of raised capital during a half-year period. This matches the characteristics of a specialized report on capital raising and usage, which aligns best with the category "Capital/Financing Update (CAP)" as it focuses on fundraising and capital usage updates rather than a full annual or interim financial report. It is not an announcement of a report but the report itself with detailed data. Therefore, the correct classification is CAP with high confidence.
2025-08-27 Chinese
关于全资子公司拟出售资产的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen Easy Biological Technology Co., Ltd. regarding the proposed sale of assets by its wholly-owned subsidiary. It details the transaction parties, asset description, transaction price, payment method, and the expected impact on the company. The document is relatively short (1550 characters) and focuses on a specific capital transaction rather than providing comprehensive financial data or a full report. It does not contain financial statements or detailed analysis but rather informs shareholders and the market about a financing-related event. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2025-08-27 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025 年半年度报告摘要' which translates to '2025 Half-Year Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, asset and liability ratios, and shareholder information. The document includes substantive financial metrics and analysis for a period shorter than a full fiscal year (half-year). It is not merely an announcement or a brief summary but contains actual financial figures and performance indicators. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 3408 characters, which is sufficient for a summary report but still contains detailed financial data, not just a notice or announcement. Hence, the classification is IR with high confidence. H1 2025
2025-08-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.